Novel Antidepressants at Psych Congress 2026
3 sessions on novel antidepressants · September 15–19, 2026, New Orleans, LA. Compare novel antidepressants at other meetings →
Wednesday, September 16
Symposium · MasterClass
MasterClass: The Road to Recovery in MDD: From Partial Response to Remission and Beyond
Christoph U. Correll · Brooke Kempf
Focuses on recognizing clinically meaningful residual depressive symptoms and using adjunctive pharmacologic options to push partial responders toward remission and sustained recovery.
Friday, September 18
Symposium · ISRP Partner Session
PMDD and Cyclical Mood Disorders: From Diagnosis to Novel Treatments
Pallavi Khanna · Kristin Lasseter
Covers diagnostic criteria and symptom tracking for premenstrual dysphoric disorder, differentiation from MDD and anxiety, and emerging neurosteroid and hormonal treatments. Developed with the International Society of Reproductive Psychiatry.
Measurement-Based Care & Diagnosis · Perinatal & Women's Mental Health
Symposium · MDD
Modern Psychopharmacology for MDD: Switching, Sequencing, and Augmentation Strategies for Partial Responders
Mark Zimmerman · Shelley Matthews
Advanced review of switching protocols, cross-tapering, and augmentation options — lithium, T3, atypicals, dextromethorphan/bupropion, vortioxetine — for patients with incomplete antidepressant response.
Depression · Lithium & Mood Stabilizers · Treatment-Resistant Depression
Other topics at this meeting
Depression 10Neuroscience & Mechanisms 10Schizophrenia & Psychosis 9Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Drug Interactions & Safety 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5